BNTC · long Benitec Biopharma INC
Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.
Sunday, July 12
Everything we published on this day.
4 stories
BNTC · long Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.
EPM · long Evolution Petroleum (EPM) is presented as a long position.
Salesforce's 8.62x forward cash flow valuation discounts AI seat cannibalization, while Agentforce, Data 360 and MuleSoft aim to retain…
Meta and Microsoft are framed as mega-cap opportunities based on business quality and valuation.